Meta-analysis and subgroup analysis showed LBZI and TRQI significantly reduced the duration of fever individually (P < 0.01, MD = -1.23, 95% CI [-1.81--0.66]).
In this stage, LBZI, SMI, and TRQI reduced the incidence of acute RP and increased TER and CR in RP patients.
In this stage, berberine, LI, and TRQI significantly reduced the incidence of RIPF.